ADME STUDY OF [14C]NETUPITANT ADMINISTERED AS AN ORAL 300 MG SUSPENSION TO HEALTHY MALE SUBJECTS

被引：0
|
作者：
Giuliano, C. [1 ]
Calcagnile, S. [1 ]
Mair, S. [2 ]
Stevens, L. [2 ]
Nisbet, I. [2 ]
机构：
[1] Helsinn Healthcare, Clin Operat, Lugano, Switzerland
[2] Quotient Biores, Radiol, Nottingham, England
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：508 / 508
页数：1
相关论文
共 50 条
  • [1] [14C]- DALCETRAPIB ADME FOLLOWING A SINGLE ORAL DOSE IN HEALTHY MALE SUBJECTS.
    Derks, M.
    Busse-Reid, R.
    Kuhlmann, O.
    Paehler, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S24 - S24
  • [2] A mass balance study of [14C]-lenalidomide following oral administration in healthy male subjects
    Chen, N.
    Kumar, G.
    Lau, H.
    Laskin, O.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1105 - 1105
  • [3] Pharmacokinetics and ADME Characterization After Oral and Intravenous Administration of [14C]-Ziftomenib in Healthy Male Participants
    Mitra, Amitava
    Ahsan, Julie Mackey
    Tabachri, Marilyn
    El-Shahat, Taha
    Leoni, Mollie
    Dale, Stephen
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (02):
  • [4] ABSORPTION DISTRIBUTION METABOLISM AND EXCRETION OF ORAL [14C]-IBREXAFUNGERP IN HEALTHY MALE SUBJECTS
    Azie, N.
    Angulo, D.
    Evans, P.
    Murphy, G.
    Ghahramani, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S12 - S12
  • [5] Oral bioavailability and disposition of [14C]omapatrilat in healthy subjects
    Malhotra, BK
    Iyer, RA
    Soucek, KM
    Behr, D
    Liao, WC
    Mitroka, JG
    Kaul, S
    Cohen, MB
    Knupp, CA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (08): : 833 - 841
  • [6] Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects
    Chen, Nianhang
    Wen, Lian
    Lau, Henry
    Surapaneni, Sekhar
    Kumar, Gondi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 789 - 797
  • [7] Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects
    Nianhang Chen
    Lian Wen
    Henry Lau
    Sekhar Surapaneni
    Gondi Kumar
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 789 - 797
  • [8] PHARMACOKINETICS AND THOROUGH ADME CHARACTERIZATION OF IV AND ORAL [14C]-LINERIXIBAT IN HEALTHY MEN
    Zamek-Gliszczynski, Maciej
    Kenworthy, David
    Bershas, David
    Sanghvi, Mitesh
    Pereira, Adrian
    Pirhalla, Jill
    Crossman, Lee
    Thorpe, Karl
    Dennison, Jeremy
    McLaughlin, Megan
    Allinder, Matthew
    Swift, Brandon
    O'Connor-Semmes, Robin
    Young, Graeme
    HEPATOLOGY, 2020, 72 : 755A - 756A
  • [9] Mass balance study of [14C] rabeprazole following oral administration in healthy subjects
    Setoyama, T.
    Drijfhout, W. J.
    de Merbel, N. C. van
    Humphries, T. J.
    Hasegawa, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2006, 44 (11) : 557 - 565
  • [10] THE MASS BALANCE RECOVERY, ABSORPTION, METABOLISM, AND EXCRETION OF [14C]-ORVEPITANT IN HEALTHY MALE SUBJECTS AFTER ORAL DOSING: RADIOSYNTHESIS OF [14C]-ORVEPITANT
    Carver, David
    Craig, Jo
    Lawrence, Ron
    Pawsey, Steve
    Cousins, Peggy
    Martos, Jose
    Shaw, Iain
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
12345